Sanofi-Aventis Continues Trials Of Dangerous Drug?

Posted by Pile (8644 views) Add this story to MyYahoo Add this article to del.icio.us Submit article to Reddit Add story to Furl Add story to StumbleUpon [E-Mail link]


A new antibiotic that has been found to cause four times the average rate of acute liver failure in adults continues in a trial for more than 900 children worldwide, despite criticism from a U.S. Food and Drug Administration official and a study consultant.

"How does one justify balancing the risk of fatal liver failure against one day less of ear pain?" asks Dr. Rosemary Johann-Liang, of the FDA's Office of Drug Safety.

The drug, Ketek (internationally known as Telithromycin) is manufactured by Sanofi-Aventis, a French pharmaceutical firm with U.S. headquarters in New Jersey. The company has defended the antibiotic as safe when used as directed. Duke University infectious disease specialist Dr. Danny Benjamin echoes the concern, calling the pediatric trial "hard to support." Benjamin is especially critical of testing the antibiotic for routine ear infections at a time when antibiotics are less frequently recommended for pediatric treatment. Yet, the FDA's own website continues to promote the pediatric trial.

Details

 

 

Comments

 
Name: (change name for anonymous posting)
Title:
Comments:
   

1 Article displayed.

Pursuant to Section 230 of Title 47 of the United States Code (47 USC § 230), BSAlert is a user-contributed editorial web site and does not endorse any specific content, but merely acts as a "sounding board" for the online community. Any and all quoted material is referenced pursuant to "Fair Use" (17 U.S.C. § 107). Like any information resource, use your own judgement and seek out the facts and research and make informed choices.

Powered by Percleus (c) 2005-2047 - Content Management System

[Percleus 0.9.4] (c) 2005, PCS